Fortrea Holdings, Inc. (FTRE)
20.00
+0.60
(+3.09%)
USD |
NASDAQ |
Oct 02, 16:00
20.00
0.00 (0.00%)
Pre-Market: 20:00
Fortrea Holdings EPS Diluted (Quarterly) : -0.1392 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1392 |
| March 31, 2026 | -0.2521 |
| December 31, 2025 | -0.3502 |
| September 30, 2025 | -0.1743 |
| June 30, 2025 | -4.138 |
| March 31, 2025 | -6.248 |
| December 31, 2024 | -0.7224 |
| September 30, 2024 | -0.3114 |
| June 30, 2024 | -1.289 |
| Date | Value |
|---|---|
| March 31, 2024 | -1.132 |
| December 31, 2023 | -0.6137 |
| September 30, 2023 | -0.1577 |
| June 30, 2023 | 0.3468 |
| March 31, 2023 | 0.1411 |
| December 31, 2022 | 0.377 |
| September 30, 2022 | 0.6824 |
| June 30, 2022 | 0.7478 |
| March 31, 2022 | 0.3668 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Charles River Laboratories International, Inc. | -0.0309 |
| IQVIA Holdings, Inc. | 1.530 |
| Medpace Holdings, Inc. | 4.250 |
| Champions Oncology, Inc. | -0.0306 |
| Avantor, Inc. | 0.0563 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -13.20M |
| Revenue (Quarterly) | 678.20M |
| Total Expenses (Quarterly) | 691.40M |
| Enterprise Value | 2.851B |
| Gross Profit Margin (Quarterly) | 17.63% |
| Profit Margin (Quarterly) | -1.95% |
| Earnings Yield | -4.58% |
| Operating Earnings Yield | 1.39% |
| Normalized Earnings Yield | -3.168 |